OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Cytomegalovirus Management in Solid Organ Transplant Recipients
Submission Deadline: November 15, 2024 (Open) Submit Now
Priyamvada Singh, MD, FASN
Assistant Professor of Medicine, Department of Medicine [section –transplant nephrology], Ohio State University, The Ohio State University College of Medicine, 395 West 12th Avenue, First floor. Columbus, OH 43210, USA
Research Interests: Long-term survival of solid organ transplant; Post-transplant diabetes; Inequity in transplant and marginal kidneys utilization; Cancer occurrences in transplanted organs
About This Topic
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation. This is seeking original manuscripts for a Special Issue on “Cytomegalovirus Management in Solid Organ Transplant Recipients” due on November 15, 2024.
Cytomegalovirus (CMV) is a common opportunistic infection affecting the outcome of solid organ transplantation [SOT]. The highest risk groups are the CMV-seronegative SOT recipients without preexisting CMV-specific immunity who receive a CMV-seropositive donor (D+/R-). Antiviral prophylaxis and preemptive therapy are the cornerstone of CMV prevention. Meanwhile, the reduction of immunosuppression and utilization of antiviral agents are the mainstays of treatment for CMV infection. Due to high cost, side effects [like acute kidney injury and bone marrow suppression], newer treatment options, future vaccine development, and strategies for managing drug-resistant CMV infection require future attention. CMV-specific cell-mediated immune assays are increasingly used to stratify the risk of CMV infection after solid organ transplantation. Still, their role in optimizing CMV prevention and treatment efforts has yet to be demonstrated.
The special issue will provide a forum for presenting evidence-based recommendations for screening, diagnosis, prevention, and treating CMV in solid organ transplant recipients.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (email@example.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!